Gene Expression Analysis Market Share

Global Gene Expression Analysis Market Overview

Gene expression analysis Market Size was valued at USD 3.9 Billion in 2022. The gene expression analysis market industry is projected to grow from USD 4.3 Billion in 2023 to USD 9.42 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.3% during the forecast period (2023 - 2032). 

One of the main market driver propelling the market's expansion is the rising use of targeted molecular therapies combined with the rising demand for tailored medications. In addition, the prevalence of chronic diseases like cancer, TB, cardiovascular disease, and genetic abnormalities is rising, which is significantly boosting market expansion. 

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Gene Expression Analysis Market Trends

• Growing demand for customized medicine is driving the market growth

Customized medical care for each patient based on their own genetic profile is the main goal of personalized medicine. Finding precise biomarkers linked to diseases, treatment outcomes, and prognosis requires gene expression analysis. Researchers can find gene signatures that correlate with disease subtypes or forecast therapy results by examining gene expression patterns. The necessity for broad gene expression research to find and validate biomarkers is driven by the demand for individualized medicine. The market for gene expression analysis benefits from ongoing technological developments such single-cell analysis, microarray technologies, and next-generation sequencing (NGS). Gene expression analysis has become more efficient, sensitive, and accurate because to these technical developments, which have also boosted its accessibility and cost-effectiveness. The demand for sophisticated platforms and technologies for gene expression analysis is growing in tandem with the demand for personalized medicine, which is fueling the expansion of the gene expression analysis market CAGR.

To encourage scientific research, including gene expression analysis, government funding agencies and organizations offer grants and financing opportunities. Researchers and organizations are able to invest in gene expression analysis because to increased government financing through funding programs and grants. The creation of fresh technology, the investigation of cutting-edge uses, and the expansion of subject-specific knowledge are all made possible by this funding. The market for gene expression analysis is expanding because it gives researchers the chance to carry out gene expression investigations. Government assistance in the form of simplified regulatory procedures and directives promotes trust and opens the path for the commercialization and wide-scale use of gene expression technology and products.

Over the projection period, it is anticipated that the development of technologically improved solutions and an increase in business activity for creating genetic treatments for various diseases will spur market expansion. For instance, the CRISPR Pioneer founded Epic Bio in July 2022 with USD 55 million in investment. The GEMS (Gene Expression Modulation System) platform, created by Epic Bio, is a cutting-edge gene expression system that allows for exact gene expression modification. The greatest library of known new modulators is found in GEMs, which also have advanced functionalities and computational genomics skills that are utilized to build guide RNAs for target genes. Additionally, in November 2021, Emmes, a Clinical Research Organization (CRO), teamed up with MedGenome to hasten the development of ground-breaking therapies for people with rare diseases. Through this agreement, people with rare disorders can access more cutting-edge medicines. Thus, driving the gene expression analysis market revenue.

Gene Expression Analysis Market Segment Insights

Gene Expression Analysis End User Insights

The gene expression analysis market segmentation, based on end user includes Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations and Others. The pharmaceutical & biotechnology companies segment dominated the market. Gene expression products are used by pharmaceutical and biotechnology businesses to achieve clinical research objectives, such as medication discovery and development. The development of tailored treatments for the treatment of cancer and rare genetic illnesses is the primary focus of biopharmaceutical businesses.

Gene Expression Analysis Product Insights

The gene expression analysis market segmentation, based on product, includes Consumables and Instruments. The consumables category generated the most income. In gene expression analysis, the consumables are crucial elements. They comprise the RNA extraction kits, RT-PCR, fluorescent dyes and probes, sequencing libraries, and other assay components necessary for gene expression studies. These consumables are commonly used in gene expression experiments and are frequently unique to the method or platform being employed.

Figure 1: Gene Expression Analysis Market, by Product, 2022 & 2032 (USD Billion) 

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Gene Expression Analysis Application Insights

The gene expression analysis market segmentation, based on application, includes Drug Discovery, Diagnosis, and Research. The research category generated the most income. Gene expression analysis is mostly utilized in research to study disease-causing organisms, to make medications to cure these disorders, and to analyze gene expression data. The research industry has a sizable portion of all three segments. However, the prevalence of gene treatments has led to a significant growth in the use of gene expression analysis in diagnostics.

Gene Expression Analysis Service Insights

The gene expression analysis market segmentation, based on product, includes Gene Expression Profiling Services, Sequencing Services, Bioinformatics Solutions and Others. The gene expression profiling services category generated the most income because there are more gene expression analysis tests being performed. Measurements of mRNA levels, which depict the pattern of genes a cell expresses at the transcription level, are made using gene expression profiling. The relative amounts of mRNA created under two or more different experimental conditions may need to be compared in order to ascertain which caused the expression of specific genes.

Gene Expression Analysis Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American gene expression analysis market area will dominate this market attributable to a number of factors, including the existence of a strong healthcare system, government laws and provisions that are supportive of drug discovery efforts, increasing spending on technology advancements, and increased investment in genomics. Thermo Fisher Scientific is one of the important firms who has been actively involved in the growth of the North American market. The presence of reputable academic institutions and research infrastructure, as well as the accessibility of cutting-edge genomic technologies and high adoption rates, all contribute to the North American market's expansion pace.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: Gene Expression Analysis Market Share By Region 2022 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe gene expression analysis market accounts for the second-largest market share. The market expansion in the European region is influenced by variables like the increasing interest of major players in the region and the growing use of cutting-edge technology. The favorable regulatory environment for genomes research, expanding emphasis on precision oncology and customized treatment, and rising investments in genomics infrastructure and research all contribute to the European market's rapid expansion. Further, the German gene expression analysis market held the largest market share, and the UK gene expression analysis market was the fastest growing market in the European region

The Asia-Pacific Gene expression analysis Market is expected to grow at the fastest CAGR from 2023 to 2032. The governments of the APAC region's increasing investments in genomics research and precision medicine, the rise in academic-industry partnerships, the expansion of the healthcare infrastructure, and the uptake of cutting-edge technologies all significantly contribute to the market's expansion in the APAC region. APAC is expected to be dominated by China and India in the years to come as a result of increasing expenditures made by public and private institutions to upgrade healthcare facilities. Moreover, China’s gene expression analysis market held the largest market share, and the Indian gene expression analysis market was the fastest growing market in the Asia-Pacific region.

Gene Expression Analysis Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the gene expression analysis market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, gene expression analysis industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the gene expression analysis industry to benefit clients and increase the market sector. In recent years, the gene expression analysis industry has offered some of the most significant advantages to market. Major players in the gene expression analysis market attempting to increase market demand by investing in research and development operations include GENERAL ELECTRIC COMPANY, Illumina, Thermo Fisher Scientific, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd, Pacific Biosciences of California, BGI, PerkinElmer Inc. and Agilent Technologies.

For use in analytical chemistry, healthcare, life science research, and other areas, Bio-Rad Laboratories Inc. (Bio-Rad) designs, produces, and sells a variety of products and systems. Reagents, equipment, lab equipment, test systems, informatics systems, test kits, and specialized quality controls are among the main products of the company. Universities, medical schools, pharmaceutical companies, governmental organizations, biotechnology researchers, reference labs, food producers, food testing labs, hospital and transfusion labs, and doctor's offices are just a few of the organizations that Bio-Rad supplies its products to.

PerkinElmer Inc. (PerkinElmer) is a provider of detection and imaging technology, consumables, informatics solutions, accessories, and a range of other services. The primary products of the company include cytogenetic reagents, ELISA kits, chromatography instruments, tissue biomarker reagents, atomic spectroscopy instruments, newborn screening devices, molecular spectroscopy, and thermal analysis instruments. It provides hospitals, clinicians, medical labs, and experts in medical research with reagents, equipment, assay platforms, and software.

Key Companies in the gene expression analysis market include

• GENERAL ELECTRIC COMPANY


• Illumina


• Thermo Fisher Scientific


• Bio-Rad Laboratories


• F. Hoffmann-La Roche Ltd


• Pacific Biosciences of California


• BGI


• PerkinElmer Inc.


• Agilent Technologies

Gene Expression Analysis Industry Developments

January 2023: The bioinformatics division of QIAGEN, Digital Insights (QDI), unveiled the QIAGEN CLC Genomics Workbench Premium, which removes the next-generation sequencing's data-analysis bottleneck. To solve the NGS data analysis bottleneck, whole genome sequencing (WGS), the whole exome sequencing (WES), and large panel sequencing data are analyzed and interpreted quickly.

November 2022: Data from the Phase 1 APOLLO single-dose investigation, presented by the breakthrough biotechnology business Silence Therapeutics Ltd, showed that patients who received the single dosage of SLN360 continued to see median decreases that were more than 80% lower.

November 2022: With the release of the ProMoSCOPE kit, Singleton Biotechnologies, a pioneer in the development of single-cell sequencing analysis solutions, has made advanced high-throughput single-cell multimodal analysis more widely available.

October 2022: In order to provide users with capabilities like providing rich and affordable single-cell and spatial sequencing data, Oxford Nanopore Technologies pl worked with 10x Genomics.

Gene Expression Analysis Market Segmentation

Gene Expression Analysis End-User Outlook (USD Billion, 2018-2032)

• Pharmaceutical & Biotechnology Companies


• Academic & Research Institutes


• Contract Research Organizations


• Others

Gene Expression Analysis Product Outlook (USD Billion, 2018-2032)

• Consumables


• Instruments

Gene Expression Analysis Application Outlook (USD Billion, 2018-2032)

• Drug Discovery


• Diagnosis


• Research

Gene Expression Analysis Service Outlook (USD Billion, 2018-2032)

• Gene Expression Profiling Services


• Sequencing Services


• Bioinformatics Solutions


• Others

Gene Expression Analysis Regional Outlook (USD Billion, 2018-2032)

• North America


• US


• Canada


• Europe


• Germany


• France


• UK


• Italy


• Spain


• Rest of Europe


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America